Zusammenfassung
Der Herpes genitalis ist eine der häufigsten sexuell übertragbaren Infektionskrankheiten und stellt eine der wichtigsten Ursachen von Erosionen und Ulcerationen im Anogenitalbereich dar (Abb. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Balfour HF (1999) Drug Therapy: Antiviral Drugs. N Engl J Med 340:1255–1268
Carney D, Ross E, Bunker C et al. (1995) A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourinary Med 70:40–45
Corey L (1994) The current trend in genital herpes. Progress in prevention. Sex Transm Dis 21:538–544
Dalkvist J, Wahlin TB, Bartsch E et al. (1995) Herpes simplex and mood: a prospective study. Psychosom Med 57:127–137
Fleming DT, McQuillan GM, Johnson RE (1997) Herpes simplex virus type 2 in the United States/1976 to 1994. N Engl J Med 337:1105–1111
Greenblatt RM, Lukehart SA, Plummer FA et al. (1988) Genital ulceration as a risk factor for human immuno-deficiency virus infection. AIDS 2:47–50
Gross G (1995) Klinik und Therapie der HSV 1-und HSV 2-Infektion. In: Ring J, Zander AR, Malin JP (Hrsg) Diagnostik und Therapie von Herpesvirus-Infektionen. TW Taschenbuch, G. Braun Fachverlage,Band 39, S. 41–62
Gross G (1999) Do we need antivirals for herpes simplex virus and human papillomavirus infection? Intern J Antimicrob Agents 12:1–3
Holwerda BC (1997) Herpesvirus proteases: targets for novel antiviral drugs. Antiviral Res 35:1–21
Keet IP, Lee FK, van Greinsven G J et al. (1990) Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourinary Med 66:330–333
Kimberlin D, Powell D, Gruber W et al. (1996) Administration of oral acyclovir, supressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 15:247–254
Petersen EE, Doerr HW, Gross G Der Herpes genitalis. Dtsch Äbl (im Druck)
Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD Jr (1996) Acyclovir suppression to prevent cesarean delivery after first — episode genital herpes. Obstet Gynecol 87:69–73
Wald A, Zeh J, Selke S et al. (1995) Virologic characteristics of subclinical and symptomatic genital herpes infection. N Engl J Med 333:770–775
Wald A, Corey L, Cone R (1997) Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 99:1092–1097
Whitley R, Arvin A, Prober C et al. (1991) Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 324:450–454
Wutzier P, Färber I, Eichhorn U Seroprävalenz von Herpes-simplex-Virus Typ 2 (HSV-2) in Deutschland. B Ges Bl (eingereicht zur Publikation)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gross, G. (2000). Therapie des Herpes genitalis. In: Plettenberg, A., Meigel, W.N., Moll, I. (eds) Dermatologie an der Schwelle zum neuen Jahrtausend. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57191-6_83
Download citation
DOI: https://doi.org/10.1007/978-3-642-57191-6_83
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63042-2
Online ISBN: 978-3-642-57191-6
eBook Packages: Springer Book Archive